Global Welcome Page

— Global Welcome Page

08.05.2025 16:00

HAYA Therapeutics banks $65 million Series A funding

08.05.2025 16:00

Led by Sofinnova Partners and Earlybird Venture Capital, Haya Therapeutics’ Series A funding round also involved a syndicate of investors, including Eli Lilly and Company. The investment will be used to advance the clinical development of its lead long non-coding RNA (lncRNA) targeting candidate HTX-001 in heart failure and the continued expansion of its RNA-guided regulatory genome pipeline development engine.

All news

07.05.2025 13:23

Digital exchange SDX attracts Citi as partner

Expected to be live by the third quarter of 2025, leading global bank Citi and SDX, part of SIX Group, are developing a scalable solution that will make shares in high-growth, venture-backed private companies much more accessible to investors.

All news

— Ad —

06.05.2025 08:28

Private biotech companies set new records

The 2025 edition of the Swiss Biotech Report, launched today by the Swiss Biotech Association together with EY and eight other partner organizations at the Swiss Biotech Day, provides key 2024 metrics and statistics compared to previous years. Overall, the figures remain solid, even though headwinds are becoming apparent. In addition, Henri B. Meier and Pascale Vonmont were honoured with the Swiss Biotech Success Stories Awards at the event.

All news

Focus

All News

biotech cleantech consumer products Deep Tech healthcare IT ICT ICT (fintech)Impact Interdisciplinary Life-Sciences medtech micro / nano

Editorials

All Editorial

Large numbers

The number of Swiss deeptech start-ups is high in absolute terms, as confirmed by a new study and this week’s news.

Facts

All Facts

Corporates seeking collaboration

Accelerators, VC funds and matchmaking from established Swiss companies

Dynamic start-up sector

Number of start-ups has quadrupled since 2003

Global blockchain hotspot

Switzerland attracts plenty of blockchain-related companies

Global market at a glance

Just three years after foundation, 60% of Swiss start-ups begin to export.

Highly active business angel

Switzerland is home to large business angel clubs

Home of industrial start-ups

Robotics, Industry 4.0 and drones are top themes for Swiss start-ups

More than USD2 billion invested in 2019

In terms of venture capital, Switzerland is one of the most attractive countries in the world

Most innovative economy

Switzerland tops the Global Innovation Index and the European Innovation Scoreboard

World-leading life sciences cluster

Dense network of universities, corporates, start-ups and service providers

Swiss Venture Capital Report TEST

The new Swiss Venture Capital Report was published on 26 January. It analyses 304 financing rounds closed in 2020 and includes further article such as an interview with Michael Hengartner, President of the ETH Board, and a list of Swiss "soonicorns". You can download it in our assets section.